We make the invisible visible
A group of researchers from Sweden and Germany provides proof of concept for implementing serial crystallography at MAX IV in a recent study. The researchers have studied three different proteins using high-viscosity extrusion and fixed-target methods. The acquired data is promising and shows a clear path towards confidently starting serial crystallography experiments at the BioMAX
MAX IV Laboratory, together with Science for Life Laboratory (SciLifeLab) and the European Spallation Source ERIC (ESS), form the joint Science Hub InfraLife, Infra Access for Life Science Sweden. Recently launched, InfraLife supports Sweden’s national investments in large-scale research infrastructure through dynamic facilitation and access to cutting-edge technology, data science, and active industry-enabling collaboration, outreach,
2019 was a landmark year for MAX IV Laboratory. Continuing the long-standing tradition of delivering innovative technical instruments and capabilities for x-ray science to the research community since MAX-lab was inaugurated in 1987, MAX IV broke new ground by opening five new beamlines to users, and bringing three more into the commissioning phase for
Building a beamline is a very long and intricate project going from discussions in the research community, funding, designing, procuring, building, installations, commissioning and finally opening for regular users. It takes at least five years from idea to realisation. Sometimes even more than a decade. MicroMAX was funded in 2018, by Novo Nordisk Fonden, but
In their quest to find new and better methods to make cancer cells more susceptible to treatment, Karin Lindkvist and her research group at Lund University in Sweden are looking into the world of molecules, using the X-rays at the MAX IV laboratory. The researchers believe that limiting the cells’ access to sugar will make
Event Date: 2020-03-02
Welcome to the MicroMAX User Meeting at the Novo Nordisk Foundation Center for Protein Research in Copenhagen, Denmark. The meeting is centred around the future MicroMAX beamline at MAX IV Laboratory that will open to users at the end of 2022. The programme includes scientific presentations illustrating the science that will be done at MicroMAX
Welcome to the MicroMAX User Meeting at the Novo Nordisk Foundation Center for Protein Research in Copenhagen, Denmark. The meeting is centred around the future MicroMAX beamline at MAX IV Laboratory that will open to users at the end of 2022. The programme includes scientific presentations illustrating the science that will be done at MicroMAX
Image: participants at the MAX IV User Meeting gathered for the opening plenary session at the Scandic Star hotel in Lund. LUND—MAX IV hosted the 31st User Meeting at the Scandic Star hotel from 23-25 September. The theme this year was Developing MAX IV: with the users, for the users. Over 300 scientists, researchers,
A new EU project in the program area Öresund-Kattegatt-Skagerak (ÖKS) has been approved. The Hanseatic League of Science (HALOS) will build a unique collaboration between Hamburg and South-West Scandinavia, bring together the four unique research facilities MAX IV, ESS, DESY and European XFEL, and create a centre for integrated, world-leading Life Science innovation and research.
The Foundation for Strategic Research, SSF, awarded over SEK 236 million to 33 different projects to promote the development of instruments, methods and technologies that provide the prerequisites for future, advanced research and innovation. One of the researchers who was granted funding is Kajsa Sigfridsson Clauss who is a scientist at the Balder beamline at